Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
IJTLD Open|December 15, 2025
The time is now: making the case for compassionate use/pre-approval access to new TB drugsA Reuter, J Stillo, S S Thi, et al.
Pulmonology|December 13, 2017
Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyondL D'Ambrosio, G Bothamley, J A Caminero Luna, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 20, 2019
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French ConsiliumL Guglielmetti, J Jaffré, C Bernard, et al.
IJTLD Open|March 17, 2025
Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacyL Kuksa, C Andrejak, B Haecker, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 11, 2020
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TBV Cox, L McKenna, R Acquah, et al.
IJTLD Open|June 18, 2025
Clinical best practices for caring for people with expanded resistance to newer TB drugsT Nkomo, Z Udwadia, D Vambe, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 19, 2019
Management of patients with multidrug-resistant tuberculosisC Lange, R E Aarnoutse, J W C Alffenaar, et al.
Trials|September 26, 2021
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trialL Guglielmetti, E Ardizzoni, M Atger, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 2, 2023
Standards for clinical trials for treating TBP du Cros, J Greig, J-W C Alffenaar, et al.
Trials|December 1, 2023
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trialS B Patil, M Tamirat, K Khazhidinov, et al.
Pageof 3